64 related articles for article (PubMed ID: 18617059)
1. Telomere aggregates in non-Hodgkin lymphoma patients at different disease stages.
Goldberg-Bittman L; Kitay-Cohen Y; Quitt M; Hadary R; Fejgin MD; Yukla M; Amiel A
Cancer Genet Cytogenet; 2008 Jul; 184(2):105-8. PubMed ID: 18617059
[TBL] [Abstract][Full Text] [Related]
2. Telomere aggregates in hepatitis C patients.
Amiel A; Fejgin MD; Goldberg-Bittman L; Sharoni R; Hadary R; Kitay-Cohen Y
Cancer Invest; 2009 Jul; 27(6):650-4. PubMed ID: 19452298
[TBL] [Abstract][Full Text] [Related]
3. Telomere aggregates in trisomy 21 amniocytes.
Hadi E; Sharony R; Goldberg-Bittman L; Biron-Shental T; Fejgin M; Amiel A
Cancer Genet Cytogenet; 2009 Nov; 195(1):23-6. PubMed ID: 19837264
[TBL] [Abstract][Full Text] [Related]
4. Short telomeres in aggressive non-Hodgkin's lymphoma as a risk factor in lymphomagenesis.
Widmann TA; Herrmann M; Taha N; König J; Pfreundschuh M
Exp Hematol; 2007 Jun; 35(6):939-46. PubMed ID: 17533048
[TBL] [Abstract][Full Text] [Related]
5. Telomere capture in hepatitis C infection.
Goldberg-Bittman L; Amiel A; Hadary R; Fejgin MD; Quitt M; Kitay-Cohen Y
Cancer Genet Cytogenet; 2009 Jun; 191(2):63-6. PubMed ID: 19446739
[TBL] [Abstract][Full Text] [Related]
6. TERC telomerase subunit gene copy number in different disease stages of non-hodgkin lymphoma and in hepatitis C.
Goldberg-Bittman L; Kitay-Cohen Y; Fejgin MD; Hadary R; Quitt M; Amiel A
Cancer Invest; 2010 Feb; 28(2):181-5. PubMed ID: 20121548
[TBL] [Abstract][Full Text] [Related]
7. Random aneuploidy in chronic hepatitis C patients.
Goldberg-Bittman L; Kitay-Cohen Y; Hadari R; Yukla M; Fejgin MD; Amiel A
Cancer Genet Cytogenet; 2008 Jan; 180(1):20-3. PubMed ID: 18068528
[TBL] [Abstract][Full Text] [Related]
8. Telomeres: the long and short of developing non-Hodgkin lymphoma.
Noy A
Clin Cancer Res; 2009 Dec; 15(23):7114-5. PubMed ID: 19934285
[TBL] [Abstract][Full Text] [Related]
9. Telomere aggregate formation in placenta specimens of pregnancies complicated with pre-eclampsia.
Sukenik-Halevy R; Fejgin M; Kidron D; Goldberg-Bittman L; Sharony R; Biron-Shental T; Kitay-Cohen Y; Amiel A
Cancer Genet Cytogenet; 2009 Nov; 195(1):27-30. PubMed ID: 19837265
[TBL] [Abstract][Full Text] [Related]
10. TP53 mutations in circulating free DNA from Egyptian patients with non-Hodgkin's lymphoma.
Hosny G; Farahat N; Hainaut P
Cancer Lett; 2009 Mar; 275(2):234-9. PubMed ID: 19046801
[TBL] [Abstract][Full Text] [Related]
11. Investigation of bone marrow involvement in malignant lymphoma using fluorescence in situ hybridization: possible utility in the detection of micrometastasis.
Huh HJ; Min HC; Cho HI; Chae SL; Lee DS
Cancer Genet Cytogenet; 2008 Oct; 186(1):1-5. PubMed ID: 18786435
[TBL] [Abstract][Full Text] [Related]
12. Telomere length in Hepatitis C.
Kitay-Cohen Y; Goldberg-Bittman L; Hadary R; Fejgin MD; Amiel A
Cancer Genet Cytogenet; 2008 Nov; 187(1):34-8. PubMed ID: 18992639
[TBL] [Abstract][Full Text] [Related]
13. Reduced telomere length variation in healthy oldest old.
Halaschek-Wiener J; Vulto I; Fornika D; Collins J; Connors JM; Le ND; Lansdorp PM; Brooks-Wilson A
Mech Ageing Dev; 2008 Nov; 129(11):638-41. PubMed ID: 18765247
[TBL] [Abstract][Full Text] [Related]
14. Telomere length in peripheral blood predicts survival in clear cell renal cell carcinoma.
Svenson U; Ljungberg B; Roos G
Cancer Res; 2009 Apr; 69(7):2896-901. PubMed ID: 19318563
[TBL] [Abstract][Full Text] [Related]
15. Association analysis between the Cdc6 G1321A polymorphism and the risk for non-Hodgkin lymphoma and hepatocellular carcinoma.
Xiong XD; Qiu FE; Fang JH; Shen Y; Liang C; Jiang W; Zhuang SM
Mutat Res; 2009 Mar; 662(1-2):10-5. PubMed ID: 19101572
[TBL] [Abstract][Full Text] [Related]
16. Modified order of allelic replication in lymphoma patients at different disease stages.
Amiel A; Elis A; Blumenthal D; Gaber E; Fejgin MD; Dubinsky R; Lishner M
Cancer Genet Cytogenet; 2001 Mar; 125(2):156-60. PubMed ID: 11369060
[TBL] [Abstract][Full Text] [Related]
17. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O
Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938
[TBL] [Abstract][Full Text] [Related]
18. Durable complete responses from therapy with combined epratuzumab and rituximab: final results from an international multicenter, phase 2 study in recurrent, indolent, non-Hodgkin lymphoma.
Leonard JP; Schuster SJ; Emmanouilides C; Couture F; Teoh N; Wegener WA; Coleman M; Goldenberg DM
Cancer; 2008 Nov; 113(10):2714-23. PubMed ID: 18853418
[TBL] [Abstract][Full Text] [Related]
19. Aneuploidy and asynchronous replication in non-alcholic fatty liver disease and cryptogenic cirrhosis.
Laish I; Mannasse-Green B; Hadary R; Konikoff FM; Amiel A; Kitay-Cohen Y
Gene; 2016 Nov; 593(1):162-166. PubMed ID: 27520584
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in indolent and aggressive lymphomas and its influence on disease outcome.
Zodelava M; Betaneli M; Tsartsidze E; Kharabadze M
Georgian Med News; 2009 Feb; (167):32-6. PubMed ID: 19276466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
